| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/07/2006 | US6994959 which compete with DNA-binding sites of regulatory proteins which regulate t-cell activity (CD28 and cytokines), preventing transcription; analyzing immunocompetence; for treatment of autoimmune diseases |
| 02/07/2006 | US6994869 amino acid source, a carbohydrate source, a lipid source, and a fatty acid delivery agent wherein the fatty acid has a bond hydrolysable in the colon to deliver free fatty acids such as short chain fatty acid acetate without having adverse affect |
| 02/07/2006 | US6994863 Pharmaceutical and cosmetic carrier and composition for topical application |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | US6994842 Aerogel powder therapeutic agents |
| 02/07/2006 | CA2450111C Crystalline forms of [r-(r*,r*)]-2-(4-fluorophenyl)-beta, delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[phenylamino)carbonyl]-1h-pyrrole-1-heptanoic acid calcium salt(2:1)(atorvastatin) |
| 02/07/2006 | CA2360308C Glucocorticoid receptor modulators |
| 02/07/2006 | CA2340202C Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/07/2006 | CA2273479C 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors |
| 02/07/2006 | CA2262454C Purine inhibitors of cyclin dependent kinase 2 and ikb-.alpha. |
| 02/07/2006 | CA2209848C Pharmaceutical and dietary composition containing sodium, potassium, magnesium and calcium ions and enzyme activators |
| 02/02/2006 | WO2006011592A1 Composition for capsule film, capsule film, and capsule made with the same |
| 02/02/2006 | WO2006011561A1 Oligosaccharide derivative having heterocyclic ring |
| 02/02/2006 | WO2006011502A1 Novel glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 02/02/2006 | WO2006011495A1 Remedy for hypercholesterolemia and/or hypertriglyceridemia |
| 02/02/2006 | WO2006011491A1 Plasmid vector, transgenic animal, method of screening drug and drug |
| 02/02/2006 | WO2006011469A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 02/02/2006 | WO2006011466A1 5-substituted-2-phenylamino-benzamide as mek inhibitor |
| 02/02/2006 | WO2006010775A1 Tyrosine derivatives as ppar-gamma-modulators |
| 02/02/2006 | WO2006010546A2 Aryl-pyridine derivatives as 11-beta-hsd1 inhibitors |
| 02/02/2006 | WO2002094990A3 Receptors and membrane-associated proteins |
| 02/02/2006 | US20060025589 2-Thiohydantoine derivative compounds and use thereof for the treatment of diabetes |
| 02/02/2006 | US20060025581 Novel human GABA receptor proteins and polynucleotides encoding the same |
| 02/02/2006 | US20060025469 Methods for decreasing beta amyloid protein |
| 02/02/2006 | US20060025464 Benzimidazole derivatives as therapeutic agents |
| 02/02/2006 | US20060025452 Method of treating demyelinating diseases or conditions |
| 02/02/2006 | US20060025442 Acylated piperidine derivatives as melanocortin-4 receptor agonists |
| 02/02/2006 | US20060025432 N-[2-[(3-Chloro-2-fluorobenzyl)thio]-6-[(2-hydroxy-1-methylethyl)amino]-4-pyrimidinyl]- 4-morpholinesulfonamide; asthma, antiallergens; rhinitis, chronic obstructive pulmonary disease, inflammatory bowel disease, irritable bowel syndrome, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis |
| 02/02/2006 | US20060025428 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 02/02/2006 | US20060025423 2,3-Dichloro-N-(3-methoxy-5-methyl-2-pyrazinyl)-benzenesulphonamide; inflammatory diseases, such as asthma |
| 02/02/2006 | US20060025413 3-(arylamino)methylene-1,3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 02/02/2006 | US20060025403 Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same |
| 02/02/2006 | US20060025374 Novel oligoribonucleotide derivatives for specific inhibition of gene expression |
| 02/02/2006 | US20060025352 Glucopyranosyloxypyrazole derivatives and use thereof in medicines |
| 02/02/2006 | US20060025350 4-hydroxy-2-hydroxymethyl-pyrrolidin-3-yl 4-O-(6-deoxy- alpha -D-glucopyranosyl)- alpha -D-glucopyranoside; alpha-amylase inhibitor; antidiabetic agents, hypoglycemic agents; side effect reduction |
| 02/02/2006 | US20060025344 Ghrelin receptor inverse agonists for regulation of feeding behaviors |
| 02/02/2006 | US20060024792 G-protein coupled receptors |
| 02/02/2006 | US20060024772 Parathyroid hormone antibodies and related methods |
| 02/02/2006 | US20060024396 Method of treating diabetes and obesity using carbohydrate absorption inhibitors |
| 02/02/2006 | US20060024389 Plant derived or derivable material with appetite suppressing activity |
| 02/02/2006 | US20060024388 Plant derived or derivable material with appetite suppressing activity |
| 02/02/2006 | US20060024334 Immunotherapeutic methods and systems |
| 02/02/2006 | US20060024293 Antibody for use in the treatment and prevention of sepsis, infections, autoimmune and graft-versus-host diseases; biodegradable, biocompatible polymer and human antibody, or an antigen-binding portion thereof, that dissociates from human TNF alpha |
| 02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
| 02/02/2006 | US20060024234 Protein markers for pharmaceuticals and related toxicity |
| 02/02/2006 | US20060024233 Use of biomolecular targets in the treatment and visualization of brain tumors |
| 02/02/2006 | DE10258008B4 Heterocyclische Fluorglycosidderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zur Herstellung dieser Arzneimittel Heterocyclic Fluorglycosidderivate, pharmaceutical compositions containing them and methods for making these drugs |
| 02/02/2006 | CA2575283A1 Method for the preparation of crystal forms of torsemide in a pure state |
| 02/02/2006 | CA2575272A1 Use of k-252a and kinase inhibitors for the prevention or treatment of hmgb1-associated pathologies |
| 02/02/2006 | CA2575243A1 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation |
| 02/02/2006 | CA2574947A1 Guanidine derivatives and therapeutic uses thereof |
| 02/02/2006 | CA2574660A1 Salt of oxalic acid with 5-[4-[2-(n-methyl-n-(2-pyridyl)-amino)ethoxy]benzyl]thiazolidin-2,4-dione and a method of its preparation and its use |
| 02/02/2006 | CA2574608A1 Novel glucitol derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 02/02/2006 | CA2574451A1 D-glucopyranosyl phenyl-substituted cyclene, medicaments containing these compounds, their use, and method for the production thereof |
| 02/02/2006 | CA2574185A1 Body fat-reducing agent |
| 02/02/2006 | CA2574021A1 Tyrosine derivatives as ppar-gamma-modulators |
| 02/02/2006 | CA2573777A1 Novel cyclohexane derivative, prodrug thereof and salt thereof, and therapeutic agent containing the same for diabetes |
| 02/02/2006 | CA2570688A1 Compounds and methods for treating dyslipidemia |
| 02/01/2006 | EP1621628A2 Talaromyces emersonii beta-glucanases |
| 02/01/2006 | EP1621548A2 Polypeptides, CDNAs encoding the same and utilization thereof |
| 02/01/2006 | EP1621540A1 Nitrogen-containing heterocyclic compounds and use thereof |
| 02/01/2006 | EP1621210A1 Adiponectin production enhancer |
| 02/01/2006 | EP1621198A2 Substituted carbostyril derivatives as 5-HT 1A receptor subtype agonists |
| 02/01/2006 | EP1621191A1 Treatment of inflammatory diseases by RXR Antagonists |
| 02/01/2006 | EP1620464A1 Combined use of keratinocyte growth factor agonists and gastrin compounds |
| 02/01/2006 | EP1620425A1 Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists |
| 02/01/2006 | EP1620423A1 Process for the preparation of (4-hydroxy-6-oxo-tetrahydropyran-2-yl) acetonitrile and derivatives thereof |
| 02/01/2006 | EP1620396A1 Process for the preparation of n-substituted 2-cyanopyrrolidines |
| 02/01/2006 | EP1620395A1 Azetidinecarboxamide derivatives and their use in the treatment of cb1 receptor mediated disorders |
| 02/01/2006 | EP1620235A1 Processing method and processing device |
| 02/01/2006 | EP1620086A1 Compounds that modulate ppar activity and methods of preparation |
| 02/01/2006 | EP1619962A1 Composition for oral administration containing capsaicinoids |
| 02/01/2006 | EP1500654B1 Benzoxazinone derivatives, the preparation and use thereof as medicaments |
| 02/01/2006 | EP1370548B1 P-thienylbenzyl-amides serving as agonists of angiotensin-(1-7)-receptors, method for the production thereof, their use and pharmaceutical preparations containing the same |
| 02/01/2006 | EP1341774B1 Fused heteroaromatic glucokinase activators |
| 02/01/2006 | EP1328266B1 Combination of fenofibrate and coenzyme q10 for the treatment of endothelial dysfunction |
| 02/01/2006 | EP1268502B1 O-aryl glucoside sglt2 inhibitors and method |
| 02/01/2006 | EP1235812B1 Pyrimidine derivatives as selective inhibitors of cox-2 |
| 02/01/2006 | EP1194409B1 Pyrazolidinol compounds |
| 02/01/2006 | EP1131302B1 Substituted 4-amino-2-aryl-cyclopenta [d]pyrimidines, their production and use and pharmaceutical preparations containing the same |
| 02/01/2006 | EP0956040B1 Stimulation of host defense mechanisms against viral challenges |
| 02/01/2006 | EP0898478B1 Stimulation of host defence mechanisms against tumors |
| 02/01/2006 | CN2754630Y Weight-reducing capsule with automatic fill in stomach |
| 02/01/2006 | CN1729192A Optical resolution of (1-benzyl-4-methylpiperidin-3-yl) -methylamine and the use thereof for the preparation of pyrrolo 2,3-pyrimidine derivatives as protein kinases inhibitors |
| 02/01/2006 | CN1729185A Nobel compounds having selective inhibiting effect at GSK3 |
| 02/01/2006 | CN1729181A Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 02/01/2006 | CN1729172A Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity |
| 02/01/2006 | CN1729158A Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 02/01/2006 | CN1729017A A preparation and method for weight reduction |
| 02/01/2006 | CN1729010A The use of melagatran for the manufacture of a medicament for the treatment of type I diabetes mellitus |
| 02/01/2006 | CN1728992A Use of alpha-phenylthiocarboxylic and alpha-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity |
| 02/01/2006 | CN1728989A Use of extracts containing phytoestrogen selectively modulating estrogen-receptor-beta. |
| 02/01/2006 | CN1726992A Chinese traditional medicine for adjusting contents of blood sugar and blood fat, and preparation method |
| 02/01/2006 | CN1726988A Combination of Chinese traditional medicine possessing function of regulating blood sugar, blood fat, preparation method |
| 02/01/2006 | CN1726987A Combined of Chinese traditional medicine for lowering blood sugar, preparation and discrimination method |
| 02/01/2006 | CN1726977A Vegetable complex liquid for heart resurrection |
| 02/01/2006 | CN1726963A Oral taking preparation of mulberry leaves possessing function for lowering blood sugar, and detection method |
| 02/01/2006 | CN1726953A Combination for treating diabetes and complicating diseases, and preparation |
| 02/01/2006 | CN1726952A Extract product of fenugreek seeds, extracting method, and application for treating diabetes and complicating disease |
| 02/01/2006 | CN1726945A Solid dispersion of extractive of general flavone of Balsamiferou Blumea Herb |